GGrantIndex
← Leaderboards

Gerald Schatten

Oregon Health And Science University

$41,450,587
Attributed
$42,172,675
Total exposure
50
Grants
31
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $8.2M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$63,609,779 · 52

By mechanism

P01$17,635,729 · 4
R25$16,247,608 · 6
R24$10,175,309 · 1
P50$7,301,971 · 3
P51$4,312,297 · 30
R37$4,190,160 · 1

Top collaborators

Most similar at Oregon Health And Science University

Same institution · by research overlap

Others in their field

Top investigators on “Research Personnel

Research focus

Research PersonnelLaboratoriesFundingProgramsTrainingCareerScientistUnited States National Institutes Of HealthInstitutionMentorsParticipantDesignUniversitiesInnovationFrontierEducational WorkshopFacultyEnsureCollaborationsAlzheimer&AposFosteringSeriesClinical ResearchInvestments

Grant awards (145)

INCLUDE Clinical Researcher Training (ICRT)$866,506
R25 · FY2025 · AG · contact PI
Frontiers in Alzheimer's and Aging Research Experiences$401,591
R25 · FY2025 · AG · contact PI
Forefronts in Substance Abuse Disorders during Pregnancy, Postpartum, and Pediatrics (FrSADP3)$375,668
R25 · FY2025 · DA · contact PI
Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)$364,750
R25 · FY2025 · AG · contact PI
Frontiers in Emerging, Reemerging and Zoonotic Diseases and Diversity (FrERZD2)$334,722
R25 · FY2025 · AI · contact PI
Frontiers in Alzheimer's and Aging Research Experiences$404,146
R25 · FY2024 · AG · contact PI
Forefronts in Substance Abuse Disorders during Pregnancy, Postpartum, and Pediatrics (FrSADP3)$377,217
R25 · FY2024 · DA · contact PI
Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)$366,824
R25 · FY2024 · AG · contact PI
Frontiers in Emerging, Reemerging and Zoonotic Diseases and Diversity (FrERZD2)$336,890
R25 · FY2024 · AI · contact PI
Frontiers in Alzheimer's and Aging Research Experiences$408,174
R25 · FY2023 · AG · contact PI
Forefronts in Substance Abuse Disorders during Pregnancy, Postpartum, and Pediatrics (FrSADP3)$382,921
R25 · FY2023 · DA · contact PI
Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)$370,460
R25 · FY2023 · AG · contact PI
Frontiers in Emerging, Reemerging and Zoonotic Diseases and Diversity (FrERZD2)$339,875
R25 · FY2023 · AI · contact PI
Frontiers in Emerging, Reemerging and Zoonotic Diseases and Diversity (FrERZD2)$470,138
R25 · FY2022 · AI · contact PI
Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)$375,451
R25 · FY2022 · AG · contact PI
Frontiers in Alzheimer's and Aging Research (FrA2R)$371,029
R25 · FY2022 · AG · contact PI
Frontiers in Addiction Research and Pregnancy$361,521
R25 · FY2022 · DA · contact PI
Frontiers in Emerging, Reemerging and Zoonotic Diseases and Diversity (FrERZD2)$143,420
R25 · FY2022 · AI · contact PI
Advancing Native American Diversity in Aging Research through Undergraduate Education (Native American ADAR)$384,117
R25 · FY2021 · AG · contact PI
Frontiers in Alzheimer's and Aging Research (FrA2R)$371,388
R25 · FY2021 · AG · contact PI
Frontiers in Addiction Research and Pregnancy$362,192
R25 · FY2021 · DA · contact PI
Frontiers in Emerging, Reemerging and Zoonotic Diseases and Diversity (FrERZD2)$352,950
R25 · FY2021 · AI · contact PI
Frontiers in Alzheimer's and Aging Research (FrA2R)$373,572
R25 · FY2020 · AG · contact PI
Frontiers in Addiction Research and Pregnancy$369,378
R25 · FY2020 · DA · contact PI
Frontiers in Stem Cells in Cancer(FriSC2)$313,740
R25 · FY2020 · CA · contact PI
Frontiers in Alzheimer's and Aging Research (FrA2R)$377,912
R25 · FY2019 · AG · contact PI
Frontiers in Addiction Research and Pregnancy$375,798
R25 · FY2019 · DA · contact PI
Frontiers in Stem Cells in Cancer(FriSC2)$313,347
R25 · FY2019 · CA · contact PI
Frontiers in Alzheimer's and Aging Research (FrA2R)$385,393
R25 · FY2018 · AG · contact PI
Frontiers in Addiction Research and Pregnancy$383,851
R25 · FY2018 · DA · contact PI
Frontiers in Stem Cells in Cancer(FriSC2)$306,910
R25 · FY2018 · CA · contact PI
Frontiers in Aging and Regeneration Research (FrARR)$363,635
R25 · FY2017 · AG · contact PI
Frontiers in Stem Cells in Cancer(FriSC2)$312,595
R25 · FY2017 · CA · contact PI
Frontiers in Aging and Regeneration Research (FrARR)$374,576
R25 · FY2016 · AG · contact PI
Frontiers in Stem Cells in Cancer(FriSC2)$292,685
R25 · FY2016 · CA · contact PI
Frontiers in Aging and Regeneration Research (FrARR)$108,000
R25 · FY2016 · AG · contact PI
Frontiers in Aging and Regeneration Research (FrARR)$364,207
R25 · FY2015 · AG · contact PI
Frontiers in Stem Cells in Cancer$308,632
R25 · FY2015 · CA · contact PI
Frontiers in Aging and Regeneration Research (FrARR)$376,339
R25 · FY2014 · AG · contact PI
Frontiers in Stem Cells in Cancer$309,321
R25 · FY2014 · CA · contact PI
Rehabilitative and Regenerative Medicine for Minority Health & Health Disparities$128,855
T15 · FY2014 · HD · contact PI
Frontiers in Aging and Regeneration Research (FrARR)$356,437
R25 · FY2013 · AG · contact PI
Frontiers in Stem Cells in Cancer$320,913
R25 · FY2013 · CA · contact PI
Rehabilitative and Regenerative Medicine for Minority Health & Health Disparities$125,811
T15 · FY2013 · HD · contact PI
Frontiers in Stem Cells and Regeneration$72,000
U13 · FY2013 · HD · contact PI
Frontiers in Aging and Regeneration Research (FrARR)$380,000
R25 · FY2012 · AG · contact PI
Frontiers in Stem Cells in Cancer$327,241
R25 · FY2012 · CA · contact PI
Rehabilitative and Regenerative Medicine for Minority Health & Health Disparities$134,974
T15 · FY2012 · HD · contact PI
Frontiers in Stem Cells and Regeneration$110,000
U13 · FY2012 · HD · contact PI
OPTIMIZATION OF METHODS FOR PRODUCTION OF BOTH ICSI- AND SCNT DERIVED BABOON$760,391
P51 · FY2011 · RR · contact PI
Frontiers in Stem Cells in Cancer$331,176
R25 · FY2011 · CA · contact PI
Frontiers in Stem Cells and Regeneration$110,000
U13 · FY2011 · HD · contact PI
NON-HUMAN PRIMATE PROPAGATION BY SOMATIC CELL NUCLEAR TRANSFER$67,609
P51 · FY2011 · RR · contact PI
METHODS FOR PRODUCTION OF ICSI AND SCNT DERIVED MACAQUE STEM CELLS$2,632
P51 · FY2011 · RR · contact PI
SEMEN COLLECTION FROM MALE BABOONS$291,016
P51 · FY2010 · RR · contact PI
OPTIMIZATION OF METHODS FOR PRODUCTION OF BOTH ICSI- AND SCNT DERIVED BABOON$260,102
P51 · FY2010 · RR · contact PI
NON-HUMAN PRIMATE PROPAGATION BY SOMATIC CELL NUCLEAR TRANSFER$115,127
P51 · FY2010 · RR · contact PI
Frontiers in Stem Cells and Regeneration$110,000
U13 · FY2010 · HD · contact PI
MICRO-RNA REGULATION IN PLURIPOTENT STEM CELLS$19,189
P51 · FY2010 · RR · contact PI
METHODS FOR PRODUCTION OF ICSI AND SCNT DERIVED MACAQUE STEM CELLS$19,188
P51 · FY2010 · RR · contact PI
OVARIAN STIMULATION IN CYNOS$19,188
P51 · FY2010 · RR · contact PI
EMBRYONIC STEM CELL DERIVATION FROM THE CHIMPANZEE$11,726
P51 · FY2010 · RR · contact PI
Pluripotent Stem Cells in Development and Disease$11,139
P01 · FY2010 · HD · contact PI
Pluripotent Stem Cells in Development and Disease$3,208,655
P01 · FY2009 · HD · contact PI
IMAGING NHES CELS IN VITRO, IN CHIMERAE, AND AFTER TRANSFER$641,749
P01 · FY2009 · HD · contact PI
DEVELOPMENT OF NEW IN VITRO AND IN VIVO MODELS OF AD$332,563
P50 · FY2009 · AG · contact PI
METHODS FOR PRODUCTION OF ICSI AND SCNT DERIVED MACAQUE STEM CELLS$246,976
P51 · FY2009 · RR · contact PI
NON-HUMAN PRIMATE PROPAGATION BY SOMATIC CELL NUCLEAR TRANSFER$165,812
P51 · FY2009 · RR · contact PI
Frontiers in Stem Cells and Regeneration$117,000
U13 · FY2009 · HD · contact PI
Pluripotent Stem Cells in Development and Disease$11,139
P01 · FY2009 · HD · contact PI
Pluripotent Stem Cells in Development and Disease$3,116,491
P01 · FY2008 · HD · contact PI
IMAGING NHES CELS IN VITRO, IN CHIMERAE, AND AFTER TRANSFER$623,298
P01 · FY2008 · HD · contact PI
RHESUS PROPAGATION BY INTRACYTOPLASMIC NUCLEAR INJECTION$461,593
P51 · FY2008 · RR · contact PI
DEVELOPMENT OF NEW IN VITRO AND IN VIVO MODELS OF AD$324,258
P50 · FY2008 · AG · contact PI
ADVERSE PREGNANCY OUTCOMES: GENETIC/ENVIRONMENTAL CAUSES$240,000
P51 · FY2008 · RR · contact PI
EGG-MEDIATED MOTILITY DURING FERTILIZATION$189,246
P51 · FY2008 · RR · contact PI
Frontiers in Human Embryonic Stem Cells$183,600
T15 · FY2008 · HL · contact PI
FRONTIERS IN HUMAN EMBRYONIC STEM CELLS$34,576
P51 · FY2008 · RR · contact PI
OPTIMIZATION OF METHODS FOR PRODUCTION OF BOTH ICSI- AND SCNT DERIVED BABOON$2,284
P51 · FY2008 · RR · contact PI
Pluripotent Stem Cells in Development and Disease$3,072,943
P01 · FY2007 · HD · contact PI
RHESUS PROPAGATION BY INTRACYTOPLASMIC NUCLEAR INJECTION$1,274,232
R24 · FY2007 · RR · contact PI
DEVELOPMENT OF NEW IN VITRO AND IN VIVO MODELS OF AD$323,921
P50 · FY2007 · AG · contact PI
Frontiers in Human Embryonic Stem Cells$183,600
T15 · FY2007 · HL · contact PI
OPTIMIZATION OF METHODS FOR PRODUCTION OF BOTH ICSI- AND SCNT DERIVED BABOON$30,570
P51 · FY2007 · RR · contact PI
Pluripotent Stem Cells in Development and Disease$3,093,173
P01 · FY2006 · HD · contact PI
RHESUS PROPAGATION BY INTRACYTOPLASMIC NUCLEAR INJECTION$1,426,167
R24 · FY2006 · RR · contact PI
Adverse Pregnancy Outcomes: Genetic/Environmental Causes$1,231,778
P50 · FY2006 · ES · contact PI
EGG-MEDIATED MOTILITY DURING FERTILIZATION$623,519
R37 · FY2006 · HD · contact PI
DEVELOPMENT OF NEW IN VITRO AND IN VIVO MODELS OF AD$195,540
P50 · FY2006 · AG · contact PI
Frontiers in Human Embryonic Stem Cells$183,600
T15 · FY2006 · HL · contact PI
Pluripotent Stem Cells in Development and Disease$3,000,000
P01 · FY2005 · HD
RHESUS PROPAGATION BY INTRACYTOPLASMIC NUCLEAR INJECTION$1,266,727
R24 · FY2005 · RR
Adverse Pregnancy Outcomes: Genetic/Environmental Causes$1,204,306
P50 · FY2005 · ES
Improving PDC/MWRI Institutional Animal Resources$640,000
G20 · FY2005 · RR
EGG-MEDIATED MOTILITY DURING FERTILIZATION$624,355
R37 · FY2005 · HD
IMAGING nhpES CELLS in vivo, in chimerae, and after transplantation$428,571
P01 · FY2005 · HD
ADMINISTRATIVE$428,571
P01 · FY2005 · HD
DEVELOPMENT OF NEW IN VITRO AND IN VIVO MODELS OF AD$202,125
P50 · FY2005 · AG
Frontiers in Human Embryonic Stem Cells$161,931
T15 · FY2005 · HL
RHESUS PROPAGATION BY INTRACYTOPLASMIC NUCLEAR INJECTION$155,762
R24 · FY2005 · RR
EGG-MEDIATED MOTILITY DURING FERTILIZATION$76,000
R37 · FY2005 · HD
RHESUS PROPAGATION BY INTRACYTOPLASMIC NUCLEAR INJECTION$1,229,832
R24 · FY2004 · RR
Adverse Pregnancy Outcomes: Genetic/Environmental Causes$1,177,302
P50 · FY2004 · ES
EGG-MEDIATED MOTILITY DURING FERTILIZATION$648,599
R37 · FY2004 · HD
Frontiers in Human Embryonic Stem Cells$161,931
T15 · FY2004 · HL
RHESUS PROPAGATION BY INTRACYTOPLASMIC NUCLEAR INJECTION$1,205,510
R24 · FY2003 · RR
Adverse Pregnancy Outcomes: Genetic/Environmental Causes$1,152,004
P50 · FY2003 · ES
EGG-MEDIATED MOTILITY DURING FERTILIZATION$521,243
R37 · FY2003 · HD
IMPROVING PDC/MWRI INSTITUTIONAL ANIMAL RESOURCES$311,147
G20 · FY2003 · RR
Frontiers in Human Embryonic Stem Cells$161,931
T15 · FY2003 · HL
EGG-MEDIATED MOTILITY DURING FERTILIZATION$114,000
R37 · FY2003 · HD
Adverse Pregnancy Outcomes: Genetic/Environmental Causes$1,158,174
P50 · FY2002 · ES
RHESUS PROPAGATION BY INTRACYTOPLASMIC NUCLEAR INJECTION$1,107,335
R24 · FY2002 · RR
EGG-MEDIATED MOTILITY DURING FERTILIZATION$569,897
R37 · FY2002 · HD
BIOMEDICAL BASIS OF INTRACYTOPLASMIC SPERM INJECTION (ICSI)$174,159
U54 · FY2002 · HD
CENTROSOME DEFECTS AS CAUSES OF MALE INFERTILITY$111,112
P51 · FY2002 · RR
MICROTUBULE REARRANGEMENT &CENTROSOME INHERITANCE DURING BOVINE FERTILIZATION$111,112
P51 · FY2002 · RR
RHESUS PROPAGATION BY INTRACYTOPLASMIC NUCLEAR INJECTION$111,112
P51 · FY2002 · RR
DISINTEGRIN INTEGRIN INVOLVEMENTS DURING SPERM OOCYTE BINDING IN PRIMATES$111,112
P51 · FY2002 · RR
EGG-MEDIATED MOTILITY DURING FERTILIZATION$76,000
R37 · FY2002 · HD
Regulation of Pregnancy in Primates$0
P50 · FY2002 · ES
RHESUS PROPAGATION BY INTRACYTOPLASMIC NUCLEAR INJECTION$1,091,343
R24 · FY2001 · RR
EGG-MEDIATED MOTILITY DURING FERTILIZATION$668,519
R37 · FY2001 · HD
BIOMEDICAL BASIS OF INTRACYTOPLASMIC SPERM INJECTION (ICSI)$174,159
U54 · FY2001 · HD
MICROTUBULE REARRANGEMENT &CENTROSOME INHERITANCE DURING BOVINE FERTILIZATION$111,112
P51 · FY2001 · RR
CENTROSOME DEFECTS AS CAUSES OF MALE INFERTILITY$111,112
P51 · FY2001 · RR
RHESUS PROPAGATION BY INTRACYTOPLASMIC NUCLEAR INJECTION$111,112
P51 · FY2001 · RR
DISINTEGRIN INTEGRIN INVOLVEMENTS DURING SPERM OOCYTE BINDING IN PRIMATES$111,112
P51 · FY2001 · RR
FRONTIERS IN REPRODUCTION: MOLECULAR &CELLULAR CONCEPTS$106,535
R13 · FY2001 · HD
FRONTIERS IN REPRODUCTION: MOLECULAR &CELLULAR CONCEPTS$39,720
R13 · FY2001 · HD
Egg-Mediated Motility During Fertilization$38,149
R37 · FY2001 · HD
RHESUS PROPAGATION BY INTRACYTOPLASMIC NUCLEAR INJECTION$945,633
R24 · FY2000 · RR
RHESUS PROPAGATION BY INTRACYTOPLASMIC NUCLEAR INJECTION$472,768
R24 · FY2000 · RR
BIOMEDICAL BASIS OF INTRACYTOPLASMIC SPERM INJECTION (ICSI)$253,423
U54 · FY2000 · HD
EGG-MEDIATED MOTILITY DURING FERTILIZATION$229,879
R37 · FY2000 · HD
FRONTIERS IN REPRODUCTION: MOLECULAR &CELLULAR CONCEPTS$98,577
R13 · FY2000 · HD
RHESUS PROPAGATION BY INTRACYTOPLASMIC NUCLEAR INJECTION (SUPPLEMENT)$60,772
P51 · FY2000 · RR
TRANSGENIC NON HUMAN PRIMATES FOR BIOMEDICAL RESEARCH$60,772
P51 · FY2000 · RR
MICROTUBULE REARRANGEMENTS &CENTROSOME INHERITANCE DURING FERTILIZATION$60,772
P51 · FY2000 · RR
PERINUCLEAR THECA IN SPERMATOGENESIS &FERTILIZATION$60,772
P51 · FY2000 · RR
EGG MEDIATED MOTILITY DURING FERTILIZATION$60,772
P51 · FY2000 · RR
CENTROSOME DEFECTS AS CAUSES OF MALE INFERTILITY$60,772
P51 · FY2000 · RR
BIOMEDICAL BASIS OF INTRACYTOPLASMIC SPERM INJECTION (ICSI)$60,772
P51 · FY2000 · RR
RHESUS PROPAGATION BY INTRACYTOPLASMIC NUCLEAR INJECTION$60,772
P51 · FY2000 · RR
FRONTIERS IN REPRODUCTION: MOLECULAR &CELLULAR CONCEPTS$3,752
R13 · FY2000 · HD